Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prime Medicine (PRME) EBT Margin (2024 - 2025)

Prime Medicine (PRME) has disclosed EBT Margin for 2 consecutive years, with 5671.24% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin fell 373464.0% year-over-year to 5671.24%, compared with a TTM value of 4422.24% through Dec 2025, up 214437.0%, and an annual FY2025 reading of 4408.48%, up 215813.0% over the prior year.
  • EBT Margin was 5671.24% for Q4 2025 at Prime Medicine, down from 4312.82% in the prior quarter.
  • Across five years, EBT Margin topped out at 1936.6% in Q4 2024 and bottomed at 25128.23% in Q3 2024.